Pages

▼

Bayer Receives FDA Approval for Kovaltry

›
  Bayer Receives FDA Approval for Kovaltry® for the Treatment of Children and Adults with Hemophilia A The U.S. Food and Drug Admin...

Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis

›
Amgen and UCB announced positive top-line results for romosozumab from the pivotal Phase 3 place B o-cont R olled study evaluat I ng ...

Aurobindo Pharma gains on USFDA nod for Naproxen Sodium Tablets

›
Aurobindo Pharma has received final approval from the US Food & Drug Administration to manufacture and market   Naproxen Sodium ...

Bulk drug exports to grow 12-14% till 2018-19

›
India's bulk   drug   exports are likely to grow at an average rate of 12-14% till 2018-19 on the back of increasing shipments to c...

Indoco Remedies get US FDA nod for its Plant

›
Indoco Remedies   has rallied 19% to Rs 314 on the National Stock Exchange (NSE) after the company received US Food and Drug Administ...

Johnson & Johnson Innovation Launches JLINX

›
Johnson & Johnson Innovation is expanding its company incubation strategy to include a new multifaceted initiative in Europe design...

SANOFI AND REGENERON STRONGLY DISAGREE IN ONGOING PATENT LITIGATION REGARDING PRALUENT

›
Sanofi   and   Regeneron Pharmaceuticals, Inc.   announced today that the companies strongly disagree with a U.S. District Court jury v...

PFIZER TO PRESENT NEW DATA ON INVESTIGATIONAL TOFACITINIB AT THE 11TH CONGRESS OF ECCO

›
Pfizer Inc announced today that seven abstracts reporting on new research for tofacitinib in ulcerative colitis (UC) and Crohn’s dis...

US FDA warns Emcure Pharma

›
  The US   Food and Drug Administration   (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying it repeatedly fudg...